(Q53631060)

16 May 2018

title

Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. (English)

1 reference

16 May 2018

author name string

Patrick J Flannery

series ordinal

1

1 reference

16 May 2018

Robert F Spurney

series ordinal

2

1 reference

16 May 2018

publication date

22 March 2006

1 reference

16 May 2018

published in

The Nephron Journals

1 reference

16 May 2018

volume

103

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

e109-18

1 reference

16 May 2018

Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis

cites work

1 reference

Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.

21 January 2018

1 reference

Signal transduction from the angiotensin II AT2 receptor

21 January 2018

1 reference

Identification of angiotensin II receptor subtypes

21 January 2018

1 reference

Characterization of angiotensin II-receptor subtypes in podocytes

21 January 2018

1 reference

Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells

21 January 2018

1 reference

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells

21 January 2018

1 reference

Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats

21 January 2018

1 reference

Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense.

21 January 2018

1 reference

Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation

21 January 2018

1 reference

Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C

21 January 2018

1 reference

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

21 January 2018

1 reference

Role of C-terminal serines in desensitization and phosphorylation of the mouse thromboxane receptor

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

Role of HER receptors family in development and differentiation.

21 January 2018

1 reference

Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells

21 January 2018

1 reference

TGF-beta signaling and the fibrotic response

21 January 2018

1 reference

High glucose induced VEGF expression via PKC and ERK in glomerular podocytes

21 January 2018

1 reference

Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells

21 January 2018

1 reference

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

21 January 2018

1 reference

Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons?

21 January 2018

1 reference

Mechanism of the process formation; podocytes vs. neurons

21 January 2018

1 reference

Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes

21 January 2018

1 reference

The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death

21 January 2018

1 reference

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis

21 January 2018

1 reference

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases

21 January 2018

1 reference

AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs.

21 January 2018

1 reference

Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2

21 January 2018

1 reference

Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity

21 January 2018

1 reference

Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck.

21 January 2018

1 reference

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000092196

1 reference

16 May 2018

1 reference

16 May 2018